(Q40433130)

20 September 2017

1 reference

title

Radioimmunotherapy of ovarian cancer (English)

1 reference

20 September 2017

Radioimmunotherapy of Ovarian Cancer (English)

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

30 May 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590766

30 May 2024

author name string

K. N. Syrigos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590766

30 May 2024

A. A. Epenetos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590766

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590766

30 May 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

http://www.liebertpub.com/doi/pdf/10.1089/hyb.1995.14.121

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

30 May 2024

1 reference

20 September 2017

volume

14

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

121-124

1 reference

Reactivity of a monoclonal antibody with human ovarian carcinoma

20 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1172/JCI110380

Ovarian cancer: new clinical approaches

2

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma

30 May 2024

3

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer

30 May 2024

9

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Monoclonal antibodies in cancer detection and therapy

30 May 2024

10

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

30 May 2024

11

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS

30 May 2024

13

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Radiolabelled monoclonal antibodies in oncology. I. Technical aspects

30 May 2024

18

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

30 May 2024

20

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture

30 May 2024

21

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

30 May 2024

22

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer

30 May 2024

25

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

British Journal of Cancer

30 May 2024

28

62

21

Meares C

1990

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Selection of radionuclides for radioimmunotherapy

30 May 2024

31

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin

30 May 2024

35

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Recombinant antibodies possessing novel effector functions

30 May 2024

38

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

30 May 2024

39

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

30 May 2024

40

1 reference

https://api.crossref.org/works/10.1089/HYB.1995.14.121

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference